The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3

Molecular Biology of the Cell

Volumn 16, Issue 10, 2005, Pages 4705-4713

  Kurahashi, Toshihiro ^a,b   Nomura, Teruaki ^a,b   Kanei Ishii, Chie ^a   Shinkai, Yoichi ^c   Ishii, Shunsuke ^a,b  

^a RIKEN TSUKUBA INSTITUTE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; NEMO LIKE KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEMATOPOIETIC CELL; METHYLATION; MOLECULAR INTERACTION; MOUSE; MULTIGENE FAMILY; NONHUMAN; ONCOGENE A MYB; ONCOGENE B MYB; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS INHIBITION; PROTO ONCOGENE; TRANSACTIVATION; UBIQUITINATION;

ANIMALS; CARRIER PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; CREB-BINDING PROTEIN; HISTONES; HUMANS; LYSINE; METHYLATION; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; WNT PROTEINS;

MAMMALIA;

EID: 26244448504     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E05-05-0470     Document Type: Article

References (53)

1. Bender, T. P., Kremer, C. S., Kraus, M., Buch, T., and Rajewsky, K. (2004). Critical functions for c-Myb at three checkpoints during thymocyte development. Nature Immunol. 5, 721-729.
2. Bessa, M., Seville, M. K., and Watson, R. J. (2001). Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator. Oncogene 20, 3376-3386.
3. Biedenkapp, H., Borgmeyer, U., Sippel, A. E., and Klempnauer, K. H. (1988). Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 335, 835-837.
4. Civenni, G., Holbro, T., and Hynes, N. E. (2003). Wnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells. EMBO Rep. 4, 166-171.
5. Dai, P., Akimaru, H., Tanaka, Y., Hou, D. X., Yasukawa, T., Kanei-Ishii, C., Takahashi, T., and Ishii, S. (1996). CBP as a transcriptional coactivator of c-Myb. Genes Dev. 10, 528-540.
6. Dutnall, R. N. (2003). Cracking the histone code: one, two, three methyls, you're out! Mol. Cell 12, 3-4.
7. Facchinetti, V., Loffarelli, L., Schreek, S., Oelgeschlager, M., Luscher, B., Introna, M., and Golay, J. (1997). Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules. Biochem. J. 324, 729-736.
8. Frampton, J., Ramqvist, T., and Graf, T. (1996). v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev. 10, 2720-2731.
9. Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-κB puzzle. Cell 109, Supplement 81-96.
10. Jenuwein, T. (2001). Re-SET-ting heterochromatin by histone methyltransferases. Trends Cell. Biol. 11, 266-273.
11. Jordan, B. K., Shen, J. H., Olaso, R., Ingraham, H. A., and Vilain, E. (2003). Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy. Proc. Natl. Acad. Sci. USA 100, 10866-10871.
12. Kanei-Ishii, C., MacMillan, E. M., Nomura, T., Sarai, A., Ramsay, R. G., Aimoto, S., Ishii, S., and Gonda, T. J. (1992). Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc. Natl. Acad. Sci. USA 89, 3088-3092.
13. Kanei-Ishii, C. et al. (2004a). Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev. 18, 816-829.
14. Kanei-Ishii, C., Nomura, T., Tanikawa, J., Ichikawa-Iwata, E., and Ishii, S. (2004b). Differential sensitivity of v-Myb and c-Myb to Wnt-1-induced protein degradation. J. Biol. Chem. 279, 44582-44589.
15. Klempnauer, K. H., Gonda, T. J., and Bishop, J. M. (1982). Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 31, 453-463.
16. Kowenz-Leutz, E., Herr, P., Niss, K., and Leutz, A. (1997). The homeobox gene GBX2, a target of the myb oncogene, mediates autocrine growth and monocyte differentiation. Cell 91, 185-195.
17. Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., and Jenuwein, T. (2001). Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116-120.
18. Ladendorff, N. E., Wu, S., and Lipsick, J. S. (2001). BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb. Oncogene 20, 125-132.
19. Lee, D., Kim, H. Z., Jeong, K. W., Shim, Y. S., Horikawa, I., Barrett, J. C., and Choe, J. (2002). Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter. J. Biol. Chem. 277, 27748-27756.
20. Leprince, D., Gegonne, A., Coll, J., de Taisne, C., Schneeberger, A., Lagrou, C., and Stehelin, D. (1983). A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 306, 395-397.
21. Li, X., and McDonnell, D. P. (2002). The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT. Mol. Cell. Biol. 22, 3663-3673.
22. Miyoshi, K. et al. (2002). Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene 21, 5548-5556.
23. Mucenski, M. L., McLain, K., Kier, A. B., Swerdlow, S. H., Schereiner, C. M., Miller, T. A., Pietryga, D. W., Scott, W. J., and Potter, S. S. (1991). A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65, 677-689.
24. Nakagoshi, H., Kanei-Ishii, C., Sawazaki, T., Mizuguchi, G., and Ishii, S. (1992). Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7, 1233-1240.
25. Nakagoshi, H., Takemoto, Y., and Ishii, S. (1993). Functional domains of the human B-myb gene product. J. Biol. Chem. 268, 14161-14167.
26. Nakayama, J., Rice, J. C., Strahl, B. D., Allis, C. D., and Grewal, S. I. (2001). Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292, 110-113.
27. Ness, S. A., Marknell, A., and Graf, T. (1989). The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59, 1115-1125.
28. Nomura, N., Takahashi, M., Matsui, M., Ishii, S., Date, T., Sasamoto, S., and Ishizaki, R. (1988). Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Res. 16, 11075-11089.
29. Nomura, T., Tanikawa, J., Akimaru, H., Kanei-Ishii, C, Ichikawa-Iwata, E., Khan, M. M., Ito, H., and Ishii, S. (2004). Oncogenic activation of c-Myb correlates with a loss of negative regulation by TIF10 and Ski. J. Biol. Chem. 279, 16715-16726.
30. Oelgeschlager, M., Janknecht, R., Krieg, J., Schreek, S., and Lüscher, B. (1996). Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativiry with NF-M. EMBO J. 15, 2771-2780.
31. Ogata, K., Morikawa, S., Nakamura, H., Sekikawa, A., Inoue, T., Kanai, H., Sarai, A., Ishii, S., and Nishimura, Y. (1994). Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices. Cell 79, 639-648.
32. Peifer, M., and Polakis, P. (2000). Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 287, 1606-1609.
33. Peters, A. H. et al. (2003). Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol. Cell 12, 1577-1589.
34. Rea, S. et al. (2000). Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593-599.
35. Rice, J. C., Briggs, S. D., Ueberheide, B., Barber, C. M., Shabanowitz, J., Hunt, D. F., Shinkai, Y., and Allis, C. D. (2003). Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol. Cell 12, 1591-1598.
36. Sano, Y., and Ishii, S. (2001). Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation. J. Biol. Chem. 276, 3674-3682.
37. Sakura, H., Kanei-Ishii, C., Nagase, T., Nakagoshi, H., Gonda, T. J., and Ishii, S. (1989). Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc. Natl. Acad. Sci. USA 86, 5758-5762.
38. Saville, M. K., and Watson, R. J. (1998). The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties. Oncogene 17, 2679-2689.
39. Schotta, G., Ebert, A., Krauss, V., Fischer, A., Hoffmann, J., Rea, S., Jenuwein, T., Dorn, R., and Reuter, G. (2002). Central role of Drosophila SU(VAR)3-9 in histone H3-K9 methylation and heterochromatic gene silencing. EMBO J. 21, 1121-1131.
40. Tachibana, M., Sugimoto, K., Fukushima, T., and Shinkai, Y. (2001). Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 276, 25309-25317.
41. Tachibana, M. et al. (2002). G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16, 1779-1791.
42. Takahashi, T., Nakagoshi, H., Sarai, A., Nomura, N., Yamamoto, T., and Ishii, S. (1995). Human A-myb gene encodes a transcriptional activator containing the negative regulatory domains. FEBS Lett. 358, 89-96.
43. Tanaka, Y., Patestos, N. P., Maekawa, T., and Ishii, S. (1999). B-myb is required for inner cell mass formation at an early stage of development. J. Biol. Chem. 274, 28067-28070.
44. Tanikawa, J., Nomura, T., Macmillan, E. M., Shinagawa, T., Jin, W., Kokura, K., Baba, D., Shirakawa, M., Gonda, T. J., and Ishii, S. (2004). p53 suppresses c-Myb-induced trans-activation and transformation by recruiting the corepressor mSin3A. J. Biol. Chem. 279, 55393-55400.
45. Taylor, D., Badiani, P., and Weston, K. (1996). A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev. 10, 2732-2744.
46. Toscani, A., Mettus, R. V., Coupland, R., Simpkins, H., Letvin, J., Orth, J., Hatton, K. S., and Reddy, E. P. (1997). Arrest of spermatogenesis and defective breast development in mice lacking A-myb. Nature 386, 713-717.
47. Trauth, K., Mutschler, B., Jenkins, N. A., Gilbert, D. J., Copelend, N. G., and Klempnauer, K.-H. (1994). Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. EMBO J. 13, 5994-6005.
48. Wells, J., and Farnham, P. J. (2002). Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 26, 48-56.
49. Weston, C. R., and Davis, R. J. (2002). The JNK signal transduction pathway. Curr. Opin. Genet. Dev. 12, 14-21.
50. Wodarz, A., and Nusse, R. (1998). Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14, 59-88.
51. Yasukawa, T., Kanei-Ishii, C., Maekawa, T., Fujimoto, J., Yamamoto, T., and Ishii, S. (1995). Increase of solubility of foreign proteins in Escherichia coli by coproduction of the bacterial thioredoxin. J. Biol. Chem. 270, 25328-25331.
52. Yang, L., Xia, L., Wu, D. Y., Wang, H., Chansky, H. A., Schubach, W. H., Hickstein, D. D., and Zhang, Y. (2002). Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor. Oncogene 21, 148-152.
53. Ziebold, U., and Klempnauer, K.-H. (1997). Linking Myb to the cell cycle: cyclin-dependent phosphorylation and regulation of A-Myb activity. Oncogene 15, 1011-1019.